|
1
|
Ng SH, Yen TC, Liao CT, Chang JT, Chan SC,
Ko SF, Wang HM and Wong HF: 18F-FDG PET and CT/MRI in oral cavity
squamous cell carcinoma: a prospective study of 124 patients with
histologic correlation. J Nucl Med. 46:1136–1143. 2005.PubMed/NCBI
|
|
2
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Penta JS, Johnson FM, Wachsman JT and
Copeland WC: Mitochondrial DNA in human malignancy. Mutat Res.
488:119–133. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McFarland R, Taylor RW and Turnbull DM:
Mitochondrial disease - its impact, etiology and pathology. Curr
Top Dev Biol. 77:113–155. 2007. View Article : Google Scholar
|
|
5
|
Stewart JB, Freyer C, Elson JL and Larsson
NG: Purifying selection of mtDNA and its implications for
understanding evolution and mitochondrial disease. Nat Rev Genet.
9:657–662. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hung WY, Wu CW, Yin PH, Chang CJ, Li AF,
Chi CW, Wei YH and Lee HC: Somatic mutations in mitochondrial
genome and their potential roles in the progression of human
gastric cancer. Biochim Biophys Acta. 1800:264–270. 2010.
View Article : Google Scholar
|
|
7
|
Wang C, Zhang F, Fan H, Peng L, Zhang R,
Liu S and Guo Z: Sequence polymorphisms of mitochondrial D-loop and
hepatocellular carcinoma outcome. Biochem Biophys Res Commun.
406:493–496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ding C, Li R, Wang P, Jin P, Li S and Guo
Z: Identification of sequence polymorphisms in the D-loop region of
mitochondrial DNA as a risk factor for lung cancer. Mitochondrial
DNA. 23:251–254. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guerra F, Kurelac I, Magini P, Cormio A,
Santini D, Ceccarelli C and Gasparre G: Mitochondrial DNA
genotyping reveals synchronous nature of simultaneously detected
endometrial and ovarian cancers. Gynecol Oncol. 122:457–458. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cai FF, Kohler C, Zhang B, Chen WJ,
Barekati Z, Garritsen HS, Lenner P, Toniolo P, Zhang JJ and Zhong
XY: Mutations of mitochondrial DNA as potential biomarkers in
breast cancer. Anticancer Res. 31:4267–4271. 2011.PubMed/NCBI
|
|
11
|
Lam ET, Bracci PM, Holly EA, Chu C, Poon
A, Wan E, White K, Kwok PY, Pawlikowska L and Tranah GJ:
Mitochondrial DNA sequence variation and risk of pancreatic cancer.
Cancer Res. 72:686–695. 2012. View Article : Google Scholar :
|
|
12
|
Czarnecka AM, Gammazza AM, Di Felice V,
Zummo G and Cappello F: Cancer as a ‘Mitochondriopathy’. J Cancer
Mol. 3:71–79. 2007.
|
|
13
|
Wong LJ, Tan DJ, Bai RK, Yehbackground KT
and Chang J: Molecular alterations in mitochondrial DNA of
hepatocellular carcinomas: is there a correlation with
clinicopathological profile? J Med Genet. 41:e652004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boland CR, Thibodeau SN, Hamilton SR,
Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA,
Fodde R, Ranzani GN and Srivastava S: A national cancer institute
workshop on microsatellite instability for cancer detection and
familial predisposition: development of international criteria for
the determination of microsatellite instability in colorectal
cancer. Cancer Res. 58:5248–5257. 1998.PubMed/NCBI
|
|
15
|
Bragoszewski P, Kupryjanczyk J, Bartnik E,
Rachinger A and Ostrowski J: Limited clinical relevance of
mitochondrial DNA mutation and gene expression analyses in ovarian
cancer. BMC Cancer. 8:2922008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Brandon M, Baldi P and Wallace DC:
Mitochondrial mutations in cancer. Oncogene. 25:4647–4662. 2006.
View Article : Google Scholar : PubMed/NCBI
|